1998
DOI: 10.1136/bjo.82.1.97
|View full text |Cite
|
Sign up to set email alerts
|

Dermatitis artefacta presenting as a basal cell carcinoma---an important clinical sign missed

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2004
2004
2019
2019

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(8 citation statements)
references
References 6 publications
(5 reference statements)
0
8
0
Order By: Relevance
“…Dermatitis artifacta can mimic recurrent herpes simplex infections, vasculitis, and basal cell carcinoma. [1][2][3] These serious conditions need to be excluded before a diagnosis of dermatitis artifacta is made.…”
Section: Discussionmentioning
confidence: 99%
“…Dermatitis artifacta can mimic recurrent herpes simplex infections, vasculitis, and basal cell carcinoma. [1][2][3] These serious conditions need to be excluded before a diagnosis of dermatitis artifacta is made.…”
Section: Discussionmentioning
confidence: 99%
“…In a right-handed person, the left side is usually involved, and the accessible body parts are usually more involved than inaccessible parts like the midline of the dorsum. Recurrent excoriation produces inflammation and lichenification of the skin, resulting in irritation and pruritus, which leads to further self-trauma and chronic dermatitis [1].…”
Section: Discussionmentioning
confidence: 99%
“…The atypical antipsychotic drug olanzapine appears to be effective in DA therapy [9]. Follow-up studies have shown that most DA patients improve significantly as a result of positive changes in their life situation and during maturation as a result of psychiatric treatment [1].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[ 2 ] Patients frequently have an impulsive personality disorder. [ 3 ] This disorder is seen more commonly in women (male to female ratio of at least 1:4), and has a broad and variable age of onset (9–73 years), with the highest frequency during adolescence and young adulthood. The prevalence is about 0.3% among dermatology patients.…”
Section: Discussionmentioning
confidence: 99%